← Back to Search

In-House Developed VR Platform - AMD, DR, Glaucoma for Visual Impairment

N/A
Waitlist Available
Led By John-Ross Rizzo, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day of intervention
Awards & highlights

Study Summary

This trial uses virtual reality to simulate different types and severities of visual impairments in order to provide a safe, controllable, and repeatable environment for development and preliminary testing of electronic travel aids.

Eligible Conditions
  • Visual Impairment
  • Diabetic Retinopathy
  • Age-Related Macular Degeneration
  • Glaucoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day of intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day of intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Average distance traveled by the participant
Average number of obstacle collisions during the trial
Average time it takes to understand how to interact with the system and run the simulation of the bus ride
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Second Set of ExperimentsExperimental Treatment1 Intervention
The anticipated number of participants is 100. Of these, 80 participants have healthy vision, and 20 have glaucoma.
Group II: First Set of ExperimentsExperimental Treatment1 Intervention
The anticipated number of participants is 336. All participants have healthy vision.

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,367 Previous Clinical Trials
839,623 Total Patients Enrolled
1 Trials studying Visual Impairment
120 Patients Enrolled for Visual Impairment
John-Ross Rizzo, MDPrincipal InvestigatorNYU Langone Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the ceiling for participants in this investigation?

"Affirmative, clinicaltrials.gov contains proof that this medical trial is currently seeking volunteers and was initially posted on October 24th 2021. The most recent amendment took place on October 6th 2022 with the aim of enrolling 446 patients from one site."

Answered by AI

Am I eligible to take part in this research endeavor?

"This research project requires the recruitment of 446 glaucoma patients between 18 and 80 years old. Furthermore, potential participants must meet general inclusion criteria as well as possess some form of visual impairment regardless of gender or severity of disease."

Answered by AI

Is the age range for this research restricted to individuals over 55?

"As specified in the study's requirements for enrolment, individuals must be between 18 and 80 years old to take part."

Answered by AI

Are any new applicants still being accepted into this investigation?

"Correct. From clinicaltrials.gov, it can be inferred that this medical research has commenced recruitment and is searching for 446 participants from a single site. This project was initially posted on October 24th 2021 with its last update being on the tenth of October 2022."

Answered by AI

Who else is applying?

What state do they live in?
California
Pennsylvania
Other
New York
How old are they?
65+
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
What site did they apply to?
NYU Langone Health
How many prior treatments have patients received?
2
3+

Why did patients apply to this trial?

I have been to multiple doctors here in Louisiana with no help, i am determined to see again!
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

Is it for me?
PatientReceived no prior treatments
~29 spots leftby Apr 2025